Matteo Trotta joined Incyte as Executive Vice President and General Manager of U.S. Dermatology in 2024 overseeing the U.S. Dermatology Business Unit including commercial and medical affairs teams. Mr. Trotta has more than 15 years of pharmaceutical industry experience, spanning multiple therapeutic areas, clinical, platforms, functions and geographies. Prior to Incyte, Mr. Trotta served as the Head of Novartis U.S. Immunology, where he led a 400-person organization across dermatology, rheumatology, auto-inflammatory rare diseases and allergy. He additionally held leadership roles in U.S. marketing and sales, enterprise strategy and global manufacturing and quality. Before joining Novartis in 2012, he was an Engagement Manager at McKinsey & Company where he served pharmaceutical and payer clients as part of their healthcare practice and held roles at GM-FIAT Worldwide Purchasing. Mr. Trotta received his Engineering Degree from Politecnico di Torino, his Master of Science in Engineering from the University of Illinois Chicago and his Master of Business Administration from Columbia Business School.

Pablo J. Cagnoni, M.D., joined Incyte in 2023 as President, Head of Research & Development. In his role, Dr. Cagnoni oversees Incyte’s research and development efforts across its portfolio of programs in Oncology, Hematology and Inflammation and Autoimmunity, including Dermatology.

Prior to joining Incyte, Dr. Cagnoni served as the Chief Executive Officer of Laronde, a company dedicated to the development of a new type of translatable ribonucleic acid (RNA) called endless RNA (eRNA), and held leadership roles at Rubius Therapeutics, Tizona Therapeutics, Onyx Pharmaceuticals and Novartis Oncology. Throughout his career as a pharmaceutical executive and oncologist, Dr. Cagnoni has advanced the development of breakthrough treatments, playing a key role in the development, approval and commercialization of more than 20 life-changing medicines.

Dr. Cagnoni earned his medical degree from the University of Buenos Aires School of Medicine. He completed his fellowship in Hematology and Oncology at the Mount Sinai Medical Center, New York, and a fellowship in Stem Cell Transplantation at the University of Colorado Health Sciences Center.

Xiaozhao Wang joined Incyte as Research Investigator in 2013, and since then has been taking on roles of increasing responsibility. Currently Dr. Wang serves as Associate Vice President, Head of Medicinal Chemistry, and oversees the Company’s Chemistry efforts on its small molecule programs. Dr. Wang joined Incyte from the University of Pennsylvania, where he conducted his postdoctoral research primarily in the field of natural product synthesis. Dr. Wang received his Bachelor of Science in Medicinal Chemistry from Tianjin University in Tianjin, China, and his doctorate degree in Organic Chemistry from The Ohio State University.

Michael Morrissey joined Incyte in 2016 as Corporate Senior Vice President and Head of Global Technical Operations. He has more than 30 years of global pharmaceutical industry experience through prior positions in research and development, quality assurance and manufacturing. Most recently, Mr. Morrissey served as Corporate Vice President, Head of International Technical Operations at Celgene International, where he built the company’s internal production and distribution capabilities and launched its drugs worldwide. Prior to Celgene, he worked for Roche for 15 years in various positions. Mr. Morrissey holds a diploma in Physics and Applied Mathematics from the University of London.

Jonathan Dickinson joined Incyte as Senior Vice President and General Manager, Europe, in 2016 after serving as Senior Vice President and General Manager, Europe, at ARIAD Pharmaceuticals (Europe) Sàrl. Prior to ARIAD, Mr. Dickinson served as European Oncology Brand Lead at Bristol-Myers Squibb and held several key leadership positions during his 13-year tenure at Hoffmann-La Roche, which took him to the U.S. and Switzerland working with three of the company’s leading oncology medicines. Mr. Dickinson began his career at Novartis, holding commercial roles in oncology and endocrinology, including Medical Sales, Product Manager and Business Director in the United Kingdom. Mr. Dickinson received his Bachelor of Science in Genetics and his Master of Business Administration from the University of Nottingham.